- Joined
- Mar 31, 2013
- Messages
- 63,556
- Reaction score
- 28,921
- Gender
- Male
- Political Leaning
- Undisclosed
Who's 'taken away the financial incentive'? If the drug you mentioned earlier was a success, your employer would stand to profit nicely for the next 8 years. There's plenty of money in drugs as is.
How else to explain:
The top 20 highest-paid biopharma CEOs
1. Len Schleifer, Regeneron $41.97 million
2. Jeffrey Leiden, Vertex Pharmaceuticals $36.64 million
3. Brent Saunders, Allergan (formerly Actavis) $36.61 million
4. Martine Rothblatt, United Therapeutics $33.21 million
etc.
The top 20 highest-paid biopharma CEOs | FiercePharma
Pharma is profitable beyond belief, even with all those generics you'd like to see disappear.
Again with the strawman!
The generic concept is great. All for it.